Cargando…
Initial application of transanal endoscopic microsurgery for high-risk lower rectal gastrointestinal stromal tumor after imatinib mesylate neoadjuvant chemotherapy: A case report
RATIONALE: The lower rectal gastrointestinal stromal tumor (GIST) is a rare entity and warrants special attentions because of the considerations of preserving of anal and urinal functions. Neoadjuvant therapy with imatinib mesylate (IM) has achieved great success in GIST, which potentially extends t...
Autores principales: | Liu, Qiaofei, Zhong, Guangxi, Zhou, Weixun, Lin, Guole |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5521910/ https://www.ncbi.nlm.nih.gov/pubmed/28723770 http://dx.doi.org/10.1097/MD.0000000000007538 |
Ejemplares similares
-
GASTROINTESTINAL STROMAL TUMOR OF THE RECTUM TREATED WITH NEOADJUVANT
IMATINIB FOLLOWED BY TRANSANAL ENDOSCOPIC MICROSURGERY
por: NAHAS, Caio Sergio Rizkallah, et al.
Publicado: (2015) -
Efficacy of Imatinib Mesylate Neoadjuvant Treatment for a Locally Advanced Rectal Gastrointestinal Stromal Tumor
por: Yoon, Kyu Jong, et al.
Publicado: (2011) -
Transanal endoscopic microsurgery for advanced polyps and early cancers in the rectum—Long-term outcome: A STROBE compliant observational study
por: al-Najami, Issam, et al.
Publicado: (2016) -
An Evaluation of Transanal Endoscopic Microsurgery for Rectal Adenoma and Carcinoma
por: Katti, G.
Publicado: (2004) -
Does transanal endoscopic microsurgery affect rectal function?
por: Khomyakov, Evgeniy, et al.
Publicado: (2023)